Description:

NSABP PROTOCOL C-09: ON-STUDY FORM NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7D974C-8A71-3E64-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7D974C-8A71-3E64-E034-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/9/15
  3. 7/3/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL C-09: ON-STUDY FORM NCT00268463

If primary colorectal tumor was resected prior to randomization, submit form within 30 days of randomization. Otherwise, submit form as soon as possible after resection of the primary colorectal tumor

Header
Patient Gender
Are data amended (If yes, check box and circle amended items)
Primary Colorectal Tumor
Classification of Colorectal Tumor
Did the patient receive adjuvant chemotherapy for the primary colorectal cancer
Was oxaliplatin chemotherapy administered
N Stage, Pathologic (primary colorectal tumor)
T Stage, Pathologic (If multiple primary colorectal tumors, report on most advanced.)

Similar models